GSK PLC (GSK)
45.07
+0.40
(+0.90%)
USD |
NYSE |
May 10, 16:00
45.07
0.00 (0.00%)
After-Hours: 20:00
GSK Free Cash Flow (Quarterly): 501.01M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 501.01M |
| December 31, 2023 | 2.958B |
| September 30, 2023 | 2.176B |
| June 30, 2023 | 949.07M |
| March 31, 2023 | -578.58M |
| December 31, 2022 | 1.674B |
| September 30, 2022 | 737.05M |
| June 30, 2022 | 1.314B |
| March 31, 2022 | 2.646B |
| December 31, 2021 | 4.424B |
| September 30, 2021 | 1.866B |
| June 30, 2021 | 1.031B |
| March 31, 2021 | -31.71M |
| December 31, 2020 | 4.212B |
| September 30, 2020 | 430.57M |
| June 30, 2020 | 2.898B |
| March 31, 2020 | 795.95M |
| December 31, 2019 | 3.574B |
| September 30, 2019 | 2.474B |
| June 30, 2019 | 962.73M |
| March 31, 2019 | 467.69M |
| December 31, 2018 | 4.748B |
| September 30, 2018 | 2.054B |
| June 30, 2018 | 1.331B |
| March 31, 2018 | 706.38M |
| Date | Value |
|---|---|
| December 31, 2017 | 2.784B |
| September 30, 2017 | 1.868B |
| June 30, 2017 | 535.18M |
| March 31, 2017 | 901.66M |
| December 31, 2016 | 3.101B |
| September 30, 2016 | 1.592B |
| June 30, 2016 | 1.090B |
| March 31, 2016 | -166.06M |
| December 31, 2015 | 1.261B |
| September 30, 2015 | 55.44M |
| June 30, 2015 | -303.21M |
| March 31, 2015 | 7.579M |
| December 31, 2014 | 2.639B |
| September 30, 2014 | 1.408B |
| June 30, 2014 | 642.38M |
| March 31, 2014 | 956.35M |
| December 31, 2013 | 2.693B |
| September 30, 2013 | 2.541B |
| June 30, 2013 | 1.959B |
| March 31, 2013 | 1.445B |
| December 31, 2012 | 2.212B |
| September 30, 2012 | -1.068B |
| June 30, 2012 | 2.191B |
| March 31, 2012 | 1.189B |
| December 31, 2011 | 2.674B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-578.58M
Minimum
Mar 2023
4.424B
Maximum
Dec 2021
1.751B
Average
1.494B
Median
Free Cash Flow (Quarterly) Benchmarks
| AstraZeneca PLC | 881.00M |
| Novo Nordisk A/S | 772.71M |
| Pfizer Inc | 386.00M |
| Sanofi SA | -- |
| Moderna Inc | -1.185B |